1. Boyle In 1924, Libman and Sacks reported valvar and;Loizou, S.; McCrea, J.D.; Rudge, A.C.; Reynolds, R.
2. revised criteria for the classification of systemic lupus erythematosus;Tan, E.M.; Cohen, A.S.; Fries, J.F.;The,1982
3. coronary artery disease with myocardial 3 Conley CL, Hartmann RC. A hemorrhagic disorder infarction, and, rarely, coronary arteritis. Reported caused by circulating anticoagulant in patients with valvar lesions have included Libman-Sacks endodisseminated lupus erythematosus;effusion
4. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants;Bowie, E.J.W.; JH, Jr, Thompson; Pascuzzi, C.A.; CA, Jr, Owen;J Lab Clin Med,1963
5. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972; 1: lupus-like illness, lupus anticoagulant activity, and 75-95. cardiolipin antibodies has not been reported before;Feinstein, D.I.; Rapaport, S.I.